LRP5 negatively regulates differentiation of monocytes through abrogation of Wnt signalling

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 2, 2014, Pages 314-325

  Borrell Pagès, Maria ^a   Romero, July Carolina ^a   Badimon, Lina ^a,b,c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Apoptosis; Cellular differentiation; HL60; LRP5; Macrophages

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LRP5 PROTEIN, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN; PROTEIN C JUN; SMALL INTERFERING RNA; WNT PROTEIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENETICS; HL 60 CELL LINE; HL60; HUMAN; MACROPHAGE; METABOLISM; MONOCYTE; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION;

APOPTOSIS; CELLULAR DIFFERENTIATION; HL60; LRP5; MACROPHAGES;

APOPTOSIS; BETA CATENIN; CELL DIFFERENTIATION; CELL MEMBRANE; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION TEST; HL-60 CELLS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MONOCYTES; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84893669261     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12190     Document Type: Article

References (45)

1. Li Y, Bu G. LRP5, a multifunctional cell surface receptor. Curr Opin Lipidol. 2004; 3: 361-3.
2. Borrell-Pagès M, Romero JC, Juan-Babot O, et al. Wnt pathway activation, cell migration, and lipid uptake is regulated by LRP5 in human macrophages. Eur Heart J. 2011; 32: 2841-50.
3. Mao J, Wang J, Liu B, et al. LRP5 binds to Axin and regulates the canonical Wnt signalling pathway. Mol Cell. 2001; 7: 801-9.
4. Logan CY, Nusse R. The Wnt signalling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20: 781-810.
5. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127: 469-80.
6. Ferrero-Miliani L, Nielsen OH, Andersen PS, et al. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol. 2007; 147: 227-35.
7. Lee H, Bae S, Choi BW. YoonY.WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line. Immunopharmacol Immunotoxicol. 2012; 34: 56-65.
8. Kim JS, Yeo S, Shin DG, et al. GSK3beta and beta-catenin pathway is involved in TLR4-mediated NADPH oxidase 1 expression in macrophages. FEBS J. 2010; 277: 2830-7.
9. Chen L, Wu Q, Guo F, et al. Expression of Dishevelled-1 in wound healing after acute myocardial infarction: possible involvement in myofibroblast proliferation and migration. J Cell Mol Med. 2004; 8: 257-64.
10. Padilla PI, Wada A, Yahiro K, et al. Morphologic differentiation of HL-60 cells is associated with appearance of RPTPbeta and induction of Helicobacter pylori VacA sensitivity. J Biol Chem. 2000; 275: 15200-6.
11. Sokoloski JA, Sartorelli AC, Rosen CA, et al. Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood. 1993; 82: 625-32.
12. Davidson G, Niehrs C. Emerging links between CDK cell cycle regulators and Wnt signalling. Trends Cell Biol. 2010; 20: 453-60.
13. Morin A, Fritsch L, Mathieu JR, et al. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence. FASEB J. 2012; 26: 460-7.
14. Roca H, Craig MJ, Ying C, et al. IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin upregulation. J Cell Biochem. 2012; 113: 1569-80.
15. Rooj AK, McNicholas CM, Bartoszewski R, et al. Glioma specific cation conductance regulates migration and cell cycle progression. J Biol Chem. 2012; 287: 4053-65.
16. Nead MA, Baglia LA, Antinore MJ, et al. Rb binds c-Jun and activates transcription. EMBO J. 1998; 17: 2342-52.
17. Mann B, Gelos M, Siedow A, et al. Target genes of beta-catenin-TCF/LEF signalling in human colorectal carcinomas. Proc Natl Acad Sci USA. 1999; 96: 1603-8.
18. Staal FJ, Weerkamp F, Baert MR, et al. Wnt target genes identified by DNA microarrays in immature CD34 + thymocytes regulate proliferation and cell adhesion. J Immunol. 2004; 172: 1099-108.
19. Linask KK, Knudsen KA. Gui YH.N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. Dev Biol. 1997; 185: 148-64.
20. Xu G, Arregui C, Lilien J. Balsamo J. PTP1B modulates the association of beta-catenin with N-cadherin through binding to an adjacent and partially overlapping target site. J Biol Chem. 2002; 277: 49989-97.
21. Haÿ E, Laplantine E, Geoffroy V, et al. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signalling, osteoblast function, and bone formation. Mol Cell Biol. 2009; 29: 953-64.
22. Slevin M, Krupinski J, Gaffney J, et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signalling pathways. Matrix Biol. 2007; 26: 58-68.
23. Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009; 10: 468-77.
24. Yeo W, Gautier J. Early neural cell death: dying to become neurons. Dev Biol. 2004; 274: 233-44.
25. Brocardo M, Henderson BR. APC shuttling to the membrane, nucleus and beyond. Trends Cell Biol. 2008; 18: 587-96.
26. Li F, Chong ZZ, Maiese K. Winding through the WNT pathway during cellular development and demise. Histol Histopathol. 2006; 21: 103-24.
27. Clément-Lacroix P, Ai M, Morvan F, et al. Lrp5-independent activation of Wnt signalling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA. 2005; 102: 17406-11.
28. Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002; 157: 303-14.
29. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004; 116: 205-19.
30. Rossig L, Haendeler J, Hermann C, et al. Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J Biol Chem. 2000; 275: 25502-7.
31. Furukawa T, Sunamura M, Motoi F, et al. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol. 2003; 162: 1807-15.
32. Welch C, Santra MK, El-Assaad W, et al. Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer Res. 2009; 69: 6782-9.
33. Kelly GL, Strasser A. The essential role of evasion from cell death in cancer. Adv Cancer Res. 2011; 111: 39-96.
34. Bernhard EJ, McKenna WG, Muschel RJ. Cyclin expression and G2-phase delay after irradiation. Radiat Res. 1994; 138: S64-7.
35. Maity A, Hwang A, Janss A, et al. Delayed cyclin B1 expression during the G2 arrest following DNA damage. Oncogene. 1996; 13: 1647-57.
36. Li Z, Xia L, Lee LM, et al. Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation. Radiat Res. 2001; 155: 543-53.
37. Yuan J, Yan R, Krämer A, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene. 2004; 23: 5843-52.
38. Good KL, Avery DT, Tangye SG. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol. 2009; 182: 890-901.
39. Porakishvili N, Memon A, Vispute K, et al. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells. Br J Haematol. 2011; 153: 486-98.
40. Baksh D, Boland GM, Tuan RS. Cross-talk between Wnt signalling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem. 2007; 101: 1109-24.
41. Yuzugullu H, Benhaj K, Ozturk N, et al. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer. 2009; 8: 90.
42. Hay E, Faucheu C, Suc-Royer I, et al. Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway. J Biol Chem. 2005; 280: 13616-23.
43. Shahi P, Park D, Pond AC, et al. Activation of Wnt signalling by chemically induced dimerization of LRP5 disrupts cellular homeostasis. PLoS ONE. 2012; 7: e30814.
44. Rajamannan NM, Subramaniam M, Caira F, et al. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation. 2005; 112: I229-34.
45. Lindvall C, Evans NC, Zylstra CR, et al. The Wnt signalling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J Biol Chem. 2006; 281: 35081-7.